Cardio Diagnostics Holdings, Inc. (CDIO) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -43832.5%, revenue growth -28.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $14825.00 |
| Revenue (TTM) | $0.0B |
| Net Margin | -43832.5% |
| Operating Margin (TTM) | -44690.7% |
| Revenue Growth (YoY) | -28.3% |
| EPS Growth (YoY) | -47.4% |
| FCF Growth (YoY) | 82.8% |
| Price / Book | 0.74 |
| Price / Sales | 378.89 |
| FCF Yield | -108.0% |
| Altman Z-Score | -3.08 (distress) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
CDIO overview · CDIO earnings · CDIO KPIs · CDIO documents · CDIO ownership · CDIO peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.